198 related articles for article (PubMed ID: 15226443)
21. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
[TBL] [Abstract][Full Text] [Related]
22. Mutations within the hMLH1 and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha.
Räschle M; Dufner P; Marra G; Jiricny J
J Biol Chem; 2002 Jun; 277(24):21810-20. PubMed ID: 11948175
[TBL] [Abstract][Full Text] [Related]
23. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
Chen J; Sadowski I
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
[TBL] [Abstract][Full Text] [Related]
24. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt.
Soliman AS; Bondy ML; Guan Y; El-Badawi S; Mokhtar N; Bayomi S; Raouf AA; Ismail S; McPherson RS; Abdel-Hakim TF; Beasley RP; Levin B; Wei Q
Int J Oncol; 1998 Jun; 12(6):1315-9. PubMed ID: 9592192
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress inactivates the human DNA mismatch repair system.
Chang CL; Marra G; Chauhan DP; Ha HT; Chang DK; Ricciardiello L; Randolph A; Carethers JM; Boland CR
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C148-54. PubMed ID: 12055083
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis of HNPCC: mutations of MMR genes.
Papadopoulos N; Lindblom A
Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.
Mihaylova VT; Bindra RS; Yuan J; Campisi D; Narayanan L; Jensen R; Giordano F; Johnson RS; Rockwell S; Glazer PM
Mol Cell Biol; 2003 May; 23(9):3265-73. PubMed ID: 12697826
[TBL] [Abstract][Full Text] [Related]
30. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.
Glaab WE; Tindall KR
Carcinogenesis; 1997 Jan; 18(1):1-8. PubMed ID: 9054582
[TBL] [Abstract][Full Text] [Related]
31. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
32. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.
Shimodaira H; Yoshioka-Yamashita A; Kolodner RD; Wang JY
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2420-5. PubMed ID: 12601175
[TBL] [Abstract][Full Text] [Related]
33. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
34. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
[TBL] [Abstract][Full Text] [Related]
35. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.
Branch P; Masson M; Aquilina G; Bignami M; Karran P
Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568
[TBL] [Abstract][Full Text] [Related]
37. Identification of mismatch repair protein complexes in HeLa nuclear extracts and their interaction with heteroduplex DNA.
Matton N; Simonetti J; Williams K
J Biol Chem; 2000 Jun; 275(23):17808-13. PubMed ID: 10748159
[TBL] [Abstract][Full Text] [Related]
38. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.
Liu T; Yan H; Kuismanen S; Percesepe A; Bisgaard ML; Pedroni M; Benatti P; Kinzler KW; Vogelstein B; Ponz de Leon M; Peltomäki P; Lindblom A
Cancer Res; 2001 Nov; 61(21):7798-802. PubMed ID: 11691795
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.
Marinovic-Terzic I; Yoshioka-Yamashita A; Shimodaira H; Avdievich E; Hunton IC; Kolodner RD; Edelmann W; Wang JY
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13993-8. PubMed ID: 18768816
[TBL] [Abstract][Full Text] [Related]
40. Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein.
Raevaara TE; Vaccaro C; Abdel-Rahman WM; Mocetti E; Bala S; Lönnqvist KE; Kariola R; Lynch HT; Peltomäki P; Nyström-Lahti M
Gastroenterology; 2003 Aug; 125(2):501-9. PubMed ID: 12891553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
